Photo from Aren Karapetyan/LinkedIn
Sep 24, 2024, 08:51
Aren Karapetyan: New Insights on Treatment for Squamous Cell Carcinoma of the Anus
Aren Karapetyan, Oncology Resident at Yerevan State Medical University, shared a post on LinkedIn:
“New Insights on Treatment for Squamous Cell Carcinoma of the Anus (SCCA).
A recent study explores the use of weekly cisplatin as a chemoradiotherapy (CRT) option for SCCA, offering promising results with reduced toxicity compared to traditional regimens.
Key findings:
- Safe and effective: Weekly cisplatin showed an acceptable acute toxicity profile and good outcomes.
- Improved compliance: Lower hematological toxicity was observed compared to historical data.
- Positive outcomes: 5-year Disease-Free Survival (DFS) was 77%, with Overall Survival (OS) at 86%.
- This approach may offer a more tolerable option for patients while maintaining high treatment efficacy.”
Authors: Anne Vittrup Jakobsen, Camilla Jensenius Skovhus Kronborg, Rikke Kjer Oksen, Birgitte Mayland Havelund, Karen Lycke Wind, Karen-Lise Garm Spindler
Source: Aren Karapetyan/LinkedIn
More posts featuring Aren Karapetyan on oncodaily.com
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 03:42
Dec 21, 2024, 03:31
Dec 20, 2024, 18:43
Dec 20, 2024, 18:34